在GPCR中高亲和激素结合的分子基础
Tony Warne1, Patricia C Edwards1, Andrew S Doré2
1Medical Research Council (MRC) Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
概括
在活性状态下,G蛋白结合受体 (GPCR) 具有较高的激动因子亲和力. 结构分析显示结合点较小,原子接触增加,解释了这种增强的亲和力.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- G蛋白结合受体 (GPCRs) 是关键的细胞表面受体.
- 与非活性状态相比,GPCR在活性状态下表现出更高的对激动剂的亲和力.
- 这种亲和差异背后的分子机制仍然不完全理解.
研究的目的:
- 阐明GPCR活性状态中激素亲和度增加的结构基础.
- 为了比较与激动剂结合的β1上腺受体 (β1AR) 的活性和非活性状态.
主要方法:
- 确定了四种β1AR的活性状态结构,这些结构与不同功能的特定纳米体和激动剂复合在一起.
- 将这些活性状态结构与先前确定的与相同配体结合的β1AR无活性状态结构进行比较.
主要成果:
- 在活性状态下与非活性状态相比,观察到骨结合部位体积的显著减少 (24 - 42%).
- 在活性状态下发现受体和配体之间的潜在键较短.
- 在活性构造中,β1AR与配体之间的原子接触增加了 (高达30%).
结论:
- 在β1AR的活性状态下,较小,更受限制的结合口袋导致原子接触的增加和更短的键.
- 这些结构变化为活性GPCR观察到的增强激素亲和力提供了分子解释.
- 这些发现适用于与GPCR结合的多种结构多样化的激动剂.
相关概念视频
Affinity and Avidity
38.7K
Overview
38.7K
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K
Electron Affinity
43.1K
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.1K
GPCRs Regulate Adenylyl Cylase Activity
7.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.4K
Glucagon-like Receptor Agonists
877
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
877
Adrenergic Agonists: Therapeutic Uses
1.8K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.8K


